Deneen Vojta, MD is the former Executive Vice President of Research and Development for UnitedHealth Group. Most recently, Dr. Vojta, was the President of Health Solutions and Innovation for TurningPoint Solutions. joined TurningPoint in 2022 as the President of Health Solutions and Innovation. In this role, Dr. Vojta was responsible for overseeing corporate strategy and driving growth through continued product development.

Dr. Deneen Vojta brings vast experience to the team as an entrepreneur and strategic thinker in the healthcare industry. She has a successful track record of accelerating the design, execution, and scaling of disruptive programs, products, and services and has built multiple businesses with successful exits. Dr. Vojta began her career at The Children’s Hospital of Philadelphia (CHOP) where she was a resident in Pediatrics and a fellow in Hematology & Oncology. Subsequently, she launched a CHOP’s pediatric hospitalist program. Dr. Vojta joined UnitedHealth Group in 2006 as the Executive Vice President of R&D after the company acquired MYnetico, a digital disease management company that she founded and served as CEO. Dr. Vojta holds an M.D. from Temple University School of Medicine, and a B.S. in Behavioral Neuroscience from University of Pittsburgh.

Dr. Vojta has received several major industry awards, including being named one of Modern Healthcare’s Top 25 Innovators, a CES Innovation Design and Engineering Innovation Honoree, and receiving an Emmy Award in 2014.